{"slideshow_credits": null, "snippet": "Johnson & Johnson and Novartis were accused of colluding to delay the availability of a less expensive version of a pain medication for cancer patients.", "abstract": "European antitrust officials accuse drug giants Johnson & Johnson and Novartis of colluding to delay availability of generic fentanyl, Johnson & Johnson drug used to ease pain in cancer patients.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "James", "role": "reported", "lastname": "KANTER", "rank": 1, "organization": ""}, {"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 2, "organization": ""}], "original": "By JAMES KANTER and KATIE THOMAS", "contributor": "James Kanter reported from Brussels and Katie Thomas from New York."}, "web_url": "http://www.nytimes.com/2013/02/01/business/global/eu-says-drug-makers-paid-to-delay-generic-version.html", "lead_paragraph": "Johnson & Johnson and Novartis were accused of colluding to delay the availability of a less expensive version of a pain medication for cancer patients.", "headline": {"seo": "Europe Says Johnson & Johnson Paid to Delay Generic Fentanyl", "main": "Europe Says Drug Makers Paid to Delay a Generic", "print_headline": "Drug Giant Paid to Stop A Generic, Europe Says"}, "_id": "510acf6800315214fbb885e6", "word_count": "1138", "multimedia": [{"height": 126, "url": "images/2013/02/01/business/EUDrug/EUDrug-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/02/01/business/EUDrug/EUDrug-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 768, "url": "images/2013/02/01/business/EUDrug/EUDrug-articleLarge.jpg", "legacy": {"xlarge": "images/2013/02/01/business/EUDrug/EUDrug-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "768"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/02/01/business/EUDrug/EUDrug-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/02/01/business/EUDrug/EUDrug-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-02-01T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Johnson & Johnson", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Almunia, Joaquin", "name": "persons", "is_major": "N", "rank": "11"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "12"}, {"value": "Novartis AG", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Sandoz International GmbH", "name": "organizations", "is_major": "N", "rank": "3"}, {"value": "Janssen-Cilag", "name": "organizations", "is_major": "N", "rank": "4"}, {"value": "Antitrust Laws and Competition Issues", "name": "subject", "is_major": "Y", "rank": "5"}, {"value": "European Commission", "name": "organizations", "is_major": "N", "rank": "6"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "7"}, {"value": "Pain-Relieving Drugs", "name": "subject", "is_major": "Y", "rank": "8"}, {"value": "Europe", "name": "glocations", "is_major": "Y", "rank": "9"}, {"value": "Cancer", "name": "subject", "is_major": "Y", "rank": "10"}], "blog": [], "subsection_name": "Global Business", "type_of_material": "News"}